FDA Hands Fast-Track Voucher to Rare Kids' Disease Drug Maker
Published Date: 4/7/2026
Notice
Summary
The FDA just gave a special fast-track ticket called a Priority Review Voucher to Immedica Pharma AB for their rare pediatric disease drug, LOARGYS, approved in February 2026. This voucher lets the company speed up the review of another medicine in the future, helping kids with rare diseases get treatments faster. It’s a big win for patients, the company, and anyone watching rare disease drug development!
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
LOARGYS approved for ARG1‑D patients
The FDA approved LOARGYS (pegzilarginase-nbln) on February 23, 2026. LOARGYS injection is indicated to treat hyperargininemia in adult and pediatric patients 2 years of age and older with Arginase 1 Deficiency (ARG1‑D), to be used with dietary protein restriction.
FDA issues Rare Pediatric Priority Review Voucher
The FDA announced it issued a priority review voucher to the sponsor, Immedica Pharma AB, for the approved rare pediatric disease product LOARGYS (approved February 23, 2026). The issuance was made under section 529 of the Federal Food, Drug, and Cosmetic Act.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-09767 — Oscar Bobo: Final Debarment Order
Oscar Bobo is officially banned for 5 years from importing any drugs into the U.S. because he repeatedly brought in mislabeled medicines that don’t follow FDA rules. He didn’t respond to the FDA’s warning, so the ban started on May 15, 2026. If he wants to end the ban early, he can apply anytime, but must follow special rules to keep his info private.
2026-09533 — Biomarker Incubator: Urinary Kidney Safety Biomarkers; Request for Information
The FDA wants your help to improve tests that spot kidney damage caused by medicines. They’re asking researchers, doctors, and companies to share data by July 13, 2026, so they can make these kidney safety markers better and faster. This could lead to safer drugs and smarter health checks, benefiting patients and the medical community alike.
2026-09508 — Azodicarbonamide (ADA); Request for Information
The FDA is asking for info about azodicarbonamide (ADA), a chemical used in some foods and food packaging, to check if it’s still safe. Food makers, scientists, and anyone with data should share what they know by July 13, 2026. This review could lead to changes in how ADA is used, affecting food companies and possibly costs down the line.
2026-09543 — Agency Information Collection Activities; Proposed Collection; Comment Request; Postmarketing Adverse Experience Reporting
The FDA wants your thoughts on how drug companies report problems after their products hit the market. This update affects drug makers and helps keep medicine safe by improving how side effects are tracked. You’ve got until July 13, 2026, to share your comments—no cost to join, just your voice!
2026-09544 — Modified Risk Tobacco Product Application: Renewal Applications for VLN® King and VLN® Menthol King, Cigarette Products Submitted by 22nd Century Group Inc.
The FDA is inviting the public to comment on the renewal of special approval for two cigarette products by 22nd Century Group Inc. These products claim to lower health risks compared to regular cigarettes. If renewed, the company can keep marketing them this way, with the comment period starting May 13, 2026.
2026-09507 — Butylated Hydroxytoluene (BHT); Request for Information
The FDA wants to know more about how butylated hydroxytoluene (BHT), a chemical used in food and food packaging, is being used and if it’s still safe. They’re asking companies, scientists, and the public to share any info by July 13, 2026. This could lead to changes in rules that affect food makers and might impact what’s allowed in your snacks and packaging.
Previous / Next Documents
Previous: 2026-06721 — Caribbean Fishery Management Council 189th Public Hybrid Meeting
The Caribbean Fishery Management Council is holding its 189th meeting on April 21-22, 2026, both in person and online. Fishermen, local businesses, and communities in the Caribbean will hear updates and discuss changes to fishery rules that could affect fishing limits and local economies. This meeting sets the stage for important decisions that could impact how fish are managed and how money flows in the region.
Next: 2026-06723 — Notice of OFAC Sanctions Actions
The U.S. Treasury’s OFAC just updated its sanctions list by removing Globe Trekkers LLC and Carlos Arnoldo Lobo, unblocking their property and interests. This means these folks are no longer restricted by U.S. sanctions, which could open up new business or financial opportunities. These changes took effect in early March 2026, so watch for any money moves or deals involving them!